According to the study published by Sciencedaily, OLE helps microglia surround and contain beta-amyloid plaques, reducing ...

The study was performed in an effort to find a treatment for glaucoma.

For many, it’s the ultimate dream – one which, with an exciting and controversial new gene therapy, is about to be put to the ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The treatment, currently designated HTX-001, is an antisense oligonucleotide, or ASO, that targets Wisper and reduces the ...

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...